We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Our Lifelong Immunity Relies on APRIL

News   Jun 03, 2020 | Original story from Tokyo Medical and Dental University

 
Our Lifelong Immunity Relies on APRIL

Credit: Department of Pediatrics, Perinatal and Maternal Medicine, TMDU

 
 
Advertisement
 

RELATED ARTICLES

Twin Study Explores Genetic Tendency to Eat High or Low Fat Foods

News

New research has found that the tendency to like fatty food is more complex than its fat content alone – it could also be related to genetic traits related to fat perception.

READ MORE

Strengthening the Body's Defenses Against Adenoviruses

News

Scientist have show that an already approved drug from cancer treatment could help against adenovirus infection by strengthening the body's viral defenses.

READ MORE

Single Dose of Tocilizumab Linked to 45% Lower Risk of Dying Among COVID-19 Patients on Ventilators

News

Critically ill COVID-19 patients who received a single dose of intravenous tocilizumab were 45% less likely to die overall, and more likely to be out of the hospital or off a ventilator one month after treatment, compared with those who didn't receive the drug, according to new research conducted by University of Michigan scientists.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cell Science Genomics Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE